MannKind (MNKD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Apr, 2026Voting matters and shareholder proposals
Election of nine director nominees to serve for the ensuing year and until successors are elected.
Advisory vote to approve executive compensation as disclosed in the proxy statement.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Provision to transact other business that may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Nine individuals nominated for election to the board, including James S. Shannon, Michael E. Castagna, and others.
Executive compensation and say-on-pay
Advisory vote scheduled to approve the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from MannKind
- Record 2025 revenue and strong Q4 growth set up major FDA catalysts for 2026.MNKD
Q4 20258 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and performance.MNKD
Proxy filing7 Apr 2026 - Diversified growth, major launches, and pipeline advances drive optimism for 2024 and beyond.MNKD
Leerink Global Healthcare Conference 202613 Mar 2026 - Double-digit growth and two major launches expected as diversification and innovation accelerate.MNKD
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Strong revenue growth, advancing pipeline, and new launches drive optimistic outlook.MNKD
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026 - Q1 revenue up 18% to $78.4M, net income up 24%, and pipeline advancing in key programs.MNKD
Q1 20253 Feb 2026 - Q2 revenue up 49% to $72.4M, pipeline advances, and liquidity strengthened by debt reduction.MNKD
Q2 20242 Feb 2026 - Strong revenue growth and major 2026 launches position the portfolio for continued expansion.MNKD
Corporate presentation26 Jan 2026 - Diversified pipeline and strong royalty streams position for growth, with key data readouts ahead.MNKD
2024 Wells Fargo Healthcare Conference22 Jan 2026